ArticleOncogenesis2018
The combination of cantharidin and antiangiogenic therapeutics presents additive antitumor effects against pancreatic cancer.
Meng-Dan Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
21 papers cite it
this papercites it